Gijsbert Honing

Mr. Gijsbert Honing

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2016 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
FWFrank Weber
Frank Weber
GHGijsbert Honing
Gijsbert Honing
GSGail P. Scoones
Gail P. Scoones

10 December 2018 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
PDF file
PKP. Krijtenburg
P. Krijtenburg
GHGijsbert Honing
Gijsbert Honing
CMC. Martini
C. Martini
EOE. Olofsen
E. Olofsen
HEH.J. van Elst
H.J. van Elst
MBMartijn Boon
Martijn Boon

26 October 2021 in Trials
Verified
Journal Article
Open access
PDF file
GHGijsbert Honing
Gijsbert Honing
GRGabby Reijnders-Boerboom
Gabby Reijnders-Boerboom
SDSalome Dell-Kuster
Salome Dell-Kuster
MVMonique van Velzen
Monique van Velzen
CMChris Martini
Chris Martini
MWMichiel Warlé
Michiel Warlé
Background: Muscle relaxants are routinely used during anesthesia to facilitate endotracheal intubation and to optimize surgical conditions. However, controversy remains about the required depth of neuromuscular block (NMB) needed for optimal surgical working conditions and how this relates to other outcomes. For instance, a deep neuromuscular block yields superior surgical working conditions compared to a standard NMB in laparoscopic surgery, however, a robust association to other (safety) outcomes has not yet been established. Methods: Trial design: an international multicenter randomized controlled double-blind strategy trial. Trial population: 922 patients planned for elective, laparoscopic or robotic, abdominal surgery. Intervention: Patients will be randomized to a deep NMB (post-tetanic count 1–2 twitches) or standard care (single-dose muscle relaxant administration at induction and repeated only if warranted by surgical team). Main trial endpoints: Primary endpoint is the difference in incidence of intraoperative adverse events during laparoscopic surgery graded according to ClassIntra® classification (i.e., ClassIntra® grade ≥ 2) between both groups. Secondary endpoints include the surgical working conditions, 30-day postoperative complications, and patients’ quality of recovery. Discussion: This trial was designed to analyze the effect of deep neuromuscular block compared to standard neuromuscular block on intra- and postoperative adverse events in patients undergoing laparoscopic surgery. Trial registration: ClinicalTrials.gov NCT04124757(EURO-RELAX); registration URL: https://clinicaltrials.gov/ct2/show/NCT04124757, registered on October 11th, 2019.

17 December 2020 in Molecules
Verified
Journal Article
Open access
PDF file
GHGijsbert Honing
Gijsbert Honing
CMChris Martini
Chris Martini
MVMonique van Velzen
Monique van Velzen
MNMarieke Niesters
Marieke Niesters
Albert DahanAlbert Dahan
Albert Dahan
MBMartijn Boon
Martijn Boon
General anesthesia is obtained by administration of potent hypnotics, analgesics and muscle relaxants. Apart from their intended effects (loss of consciousness, pain relief and muscle relaxation), these agents profoundly affect the control of breathing, in part by an effect within the peripheral chemoreflex loop that originates at the carotid bodies. This review assesses the role of cholinergic chemotransmission in the peripheral chemoreflex loop and the mechanisms through which muscle relaxants and hypnotics interfere with peripheral chemosensitivity. Additionally, consequences for clinical practice are discussed.